TABLE 2.
Prevalence of anti-MCV and anti-BKV antibodies observed in Belgium and Italy
Country | Age (yr) | No. of antibody-positive subjects/total no. of subjects examined (%) |
|||||
---|---|---|---|---|---|---|---|
Anti-MCV antibody |
Anti-BKV antibody |
||||||
Male | Female | Total | Male | Female | Total | ||
Belgium | 18-25 | 78/101 (77) | 78/101 (77) | 92/101 (92) | 92/101 (92) | ||
Italy | 18-39 | 28/32 (88) | 26/42 (62) | 54/74 (73) | 29/32 (91) | 32/42 (76) | 61/74 (82) |
40-64 | 27/30 (90) | 40/50 (80) | 67/80 (84) | 23/30 (77) | 29/50 (58) | 52/80 (65) | |
65-85 | 14/20 (70) | 15/20 (75) | 29/40 (73) | 10/20 (50) | 13/20 (65) | 23/40 (58) | |
Total | 69/82 (84) | 81/112 (72) | 150/194 (77) | 62/82 (76) | 74/112 (66) | 136/194 (70) | |
Total | 228/295 (77) | 228/295 (77) |